-+ 0.00%
-+ 0.00%
-+ 0.00%

ERNEXA THERAPEUTICS - PLANS IND SUBMISSION FOR ERNA-101 IN Q3 2026 AND PHASE 1 STUDY IN Q4 2026

Reuters·06/17/2026 12:48:07

Please log in to view news